Close Menu

NEW YORK – Researchers at the UNC Eshelman School of Pharmacy, the National Institutes of Health, and elsewhere have developed a CRISPR-Cas9-based system that uses chemical epigenetic modifiers (CEMs) to enable dose-dependent activation of gene expression without the use of exogenous transcription regulatory proteins.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.